* Core Laboratories Inc CLB.N reported quarterly adjusted
earnings of 25 cents per share for the quarter ended January
1, higher than the same quarter last year, when the company
reported EPS of 22 cents. The mean expectation of
seven analysts for the quarter was for earnings of 23 cents per
share. Wall Street expected results to range from 17 cents to 26
cents per share.
* Revenue rose 7.2% to $134.40 million from a year ago;
analysts
expected $134.04 million.
* Core Laboratories Inc's reported EPS for the quarter was
25
cents.
* The company reported quarterly net income of $11.75
million.
* Core Laboratories Inc shares had fallen by 6.9% this
quarter and
lost 2.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 5.6%
in the last three months.
* In the last 30 days, two analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 5
"hold" and 2 "sell" or "strong sell."
* The average consensus recommendation for the business
support
services peer group is also "hold"
Wall Street's median 12-month price target for Core Laboratories
Inc is 18.00
This summary was machine generated from LSEG data October 24 at
03:00 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.23 0.25 Beat
Jun. 30 2024 0.22
Mar. 31 2024 0.16 0.19 Beat
Dec. 31 2023 0.19 0.19 Met